Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases

Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases

US Patent 6133260 · Granted Oct 17, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for preparing substituted cyclohexane amino acid esters and spiroketal-s2024
Penflufen as a wood preservative against wood-destroying basidiomycetes2023
Process for preparing 2,6-dialkylphenylacetic acids2023
Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives2022
Process for preparing esters of N-acylated amino acids with acid-labile keto pro2022
Process for preparing spiroketal-substituted cyclic ketoenols2022
Penflufen polymer particles2020
Catalytic hydrogenation of nitriles2020
Process for preparing 3-chloro-2-vinylphenylsulfonates2020
Process for preparing substituted 2-arylethanols2019
Method for synthesizing 2-alkyl-4-trifluoromethyl-3-alkylsulfonylbenzoic acids2019
Catalytic hydrogenation of nitriles2019